Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$2.89 -0.46 (-13.73%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.94 +0.05 (+1.73%)
As of 04/17/2025 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERO vs. SSKN, BTCY, NURO, INBS, POAI, MHUA, IINN, DHAI, TNON, and LYRA

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include STRATA Skin Sciences (SSKN), Biotricity (BTCY), NeuroMetrix (NURO), Intelligent Bio Solutions (INBS), Predictive Oncology (POAI), Meihua International Medical Technologies (MHUA), Inspira Technologies Oxy B.H.N. (IINN), DIH Holding US (DHAI), Tenon Medical (TNON), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry.

Venus Concept vs.

STRATA Skin Sciences (NASDAQ:SSKN) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, valuation and community ranking.

32.4% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 49.0% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

STRATA Skin Sciences has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.

STRATA Skin Sciences has higher earnings, but lower revenue than Venus Concept. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STRATA Skin Sciences$33.56M0.31-$10.83M-$2.69-0.94
Venus Concept$64.83M0.03-$37.25M-$77.35-0.04

STRATA Skin Sciences has a net margin of -28.72% compared to Venus Concept's net margin of -74.62%. Venus Concept's return on equity of 0.00% beat STRATA Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
STRATA Skin Sciences-28.72% -69.33% -17.55%
Venus Concept -74.62%N/A -47.46%

STRATA Skin Sciences received 190 more outperform votes than Venus Concept when rated by MarketBeat users. However, 65.38% of users gave Venus Concept an outperform vote while only 64.00% of users gave STRATA Skin Sciences an outperform vote.

CompanyUnderperformOutperform
STRATA Skin SciencesOutperform Votes
224
64.00%
Underperform Votes
126
36.00%
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%

In the previous week, Venus Concept had 1 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 1 mentions for Venus Concept and 0 mentions for STRATA Skin Sciences. Venus Concept's average media sentiment score of 0.20 beat STRATA Skin Sciences' score of 0.00 indicating that Venus Concept is being referred to more favorably in the news media.

Company Overall Sentiment
STRATA Skin Sciences Neutral
Venus Concept Neutral

STRATA Skin Sciences presently has a consensus price target of $6.00, suggesting a potential upside of 137.15%. Given STRATA Skin Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe STRATA Skin Sciences is more favorable than Venus Concept.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STRATA Skin Sciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Venus Concept
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

STRATA Skin Sciences beats Venus Concept on 10 of the 18 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.05M$4.07B$5.31B$7.35B
Dividend YieldN/A46.44%5.45%4.29%
P/E Ratio-0.3628.0921.9417.81
Price / Sales0.0347.06380.9597.70
Price / CashN/A51.0838.2634.64
Price / Book-1.195.816.453.98
Net Income-$37.25M$67.09M$3.22B$247.81M
1 Month Performance-11.08%-11.64%-9.76%-7.91%
1 Year Performance-67.76%14.55%11.49%1.53%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
0.7428 of 5 stars
$2.89
-13.7%
N/A-68.7%$2.05M$64.83M-0.36410Gap Down
SSKN
STRATA Skin Sciences
2.9824 of 5 stars
$2.52
-0.4%
$6.00
+138.1%
-49.9%$10.51M$33.56M-0.95120
BTCY
Biotricity
N/A$0.42
+0.2%
N/A-71.6%$10.46M$12.06M-0.3940
NURO
NeuroMetrix
1.0584 of 5 stars
$4.37
-0.9%
N/A+20.7%$9.00M$3.03M-0.9520Short Interest ↓
INBS
Intelligent Bio Solutions
0.1178 of 5 stars
$1.27
flat
N/A-57.5%$8.62M$3.03M0.0010Short Interest ↑
Negative News
POAI
Predictive Oncology
1.4121 of 5 stars
$0.96
-4.0%
$3.00
+212.5%
-18.7%$8.58M$1.62M-0.3130Short Interest ↑
Gap Down
MHUA
Meihua International Medical Technologies
1.7467 of 5 stars
$0.32
-0.7%
N/A-51.0%$7.97M$94.25M0.00620Short Interest ↓
Positive News
Gap Down
IINN
Inspira Technologies Oxy B.H.N.
1.2207 of 5 stars
$0.61
-0.3%
N/A-67.6%$7.75MN/A0.0020Short Interest ↓
News Coverage
Gap Up
DHAI
DIH Holding US
0.5331 of 5 stars
$0.15
+11.1%
N/A-88.3%$7.15M$64.47M-0.50N/AGap Down
High Trading Volume
TNON
Tenon Medical
1.4532 of 5 stars
$1.14
+2.7%
$4.67
+309.4%
+49.3%$7.07M$3.28M-0.048
LYRA
Lyra Therapeutics
1.7682 of 5 stars
$0.11
+4.0%
$1.25
+1,075.9%
-98.4%$7.00M$1.53M-0.0750Negative News

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners